Nordhealth AS

Nordhealth AS

27.00
NOK
0.00
(0.00%)
-2.28EPS
2.05BMarket Cap
Nov 10Next Earn
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.28
0.25
0.39
0.47
0.58
0.65
0.67
Basic EPS, GAAP
0.04
-0.06
-0.18
-0.14
-0.1
-0.16
-0.2
Free Cash Flow per Basic Share
0.07
0.03
-0.16
-0.14
-0.04
-0.06
-0.09
Dividend per Share
- -
0.05
- -
- -
- -
- -
- -
Book Value per Share
0.06
1.43
1.23
1.05
0.93
0.78
0.7
Tangible Book Value per Share
-0.02
0.84
0.38
0.27
0.24
0.17
0.12
Basic Weighted Avg Shares
45
80
80
79
79
79
79
Sales/Revenue/Turnover
13
20
31
37
46
51
53
Operating Margin (%)
15.56
-21.96
-47.28
-30.92
-16.91
-24.52
-28.45
Depreciation Expense
2
4
9
10
11
11
12
Net Income, GAAP
2
-5
-14
-11
-8
-13
-16
Effective Tax Rate (%)
3.65
- -
- -
- -
- -
- -
- -
Profit Margin (%)
15.2
-23.31
-45.94
-30.23
-16.8
-24.94
-29.94
Working Capital
2
66
30
19
18
12
8
LT Debt
- -
- -
- -
- -
- -
- -
- -
Total Equity
5
115
99
83
74
62
55
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-7.92
-13.38
-12.27
-9.81
-18.76
-25.83

Capital Structure

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
79
79
79
Market Capitalization
247
195
181

Working Capital

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
22
24
22
Cash, Cash Equivalents & STI
15
15
13
Accounts Receivable, Net
5
6
7
Inventories
- -
- -
- -
Total Current Liabilities
10
15
14
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
430.8%
-16.4%
Free Cash Flow
- -
-154.68%
37.89%
Net Income, GAAP
- -
-26.33%
65.25%
Sales/Revenue/Turnover
- -
33.39%
11.31%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
10
12
11
12
46
2025
12
13
13
13
51
2026
13
14
- -
- -
- -

Quarterly Earnings Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.03
-0.02
-0.01
-0.04
-0.1
2025
-0.04
-0.04
-0.03
-0.06
-0.16
2026
-0.07
-0.05
- -
- -
- -

Quarterly Dividends Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Charles William MacBain
Full Time Employees
464
Sector
Technology services
Industry
Packaged software
Address
Hasleveien 28A Helsinki Finland 0571
IPO Date
Jun 3, 2021
Business
Nordhealth AS Nordhealth AS (NORDH.OL) provides cloud-based healthcare Software-as-a-Service (SaaS) solutions focused on practice management software (PMS) for veterinary clinics and therapy professionals; its core products include Provet Cloud, a leading veterinary PMS that streamlines operations, patient records, booking, and invoicing; Diarium and the Therapy Unified Platform, PMS solutions for therapists, psychologists, psychotherapists, and physiotherapists that handle sessions, scheduling, and billing; EasyPractice, a flagship PMS for therapists following its recent acquisition; Vetera, a PMS for veterinarians in Germany, Austria, and Switzerland; and additional veterinary PMS brands such as Vetserve, Sanimalis, Vetvision, and Vetera; the company also offers Nordhealth Connect, a communication platform linking patients and professionals, Navisec for digital training, and ancillary services including SaaS implementation, consultancy, education, data migration, and the nordhealth.fi consumer booking portal. Nordhealth AS serves over 13,000 clinics and hospitals and more than 60,000 healthcare professionals across 25 countries, primarily in the Nordics (Norway, Finland, Sweden, Denmark), Germany, the UK, and internationally including the US; it targets veterinary practices and therapy businesses to enhance care efficiency, time savings, and growth. Founded in 2001 and headquartered in Oslo, Norway, the company acquires, develops, migrates, and manages its PMS portfolio; recent developments include the 2024 acquisitions of EasyPractice to bolster its therapy flagship and Vetera for veterinary expansion, rapid rollout of Provet Cloud to CVS Group's over 300 UK clinics with further Vets4Pets (450 clinics) and a major US chain (over 200 locations) onboarding in 2025, appointment of Karan Walia as CEO of the Therapy business unit in September 2024, launch of the nordhealth.fi platform attracting over 1,400 paying therapists by year-end 2024, and a prior €120M funding raise.